137 related articles for article (PubMed ID: 38158257)
1. Kaposiform Hemangioendothelioma with Bone Destruction: A 16-Year Follow-Up Cohort Study of the Clinical Characteristics and Prognosis.
Qiu T; Zhang Z; Liu J; Zhou J; Gong X; Lan Y; Zhang X; Chen S; Ji Y
J Pediatr Surg; 2024 Apr; 59(4):599-604. PubMed ID: 38158257
[TBL] [Abstract][Full Text] [Related]
2. Kaposiform haemangioendothelioma: clinical features, complications and risk factors for Kasabach-Merritt phenomenon.
Ji Y; Yang K; Peng S; Chen S; Xiang B; Xu Z; Li Y; Wang Q; Wang C; Xia C; Li L; Liu X; Lu G; Yang G; Wu H
Br J Dermatol; 2018 Aug; 179(2):457-463. PubMed ID: 29603128
[TBL] [Abstract][Full Text] [Related]
3. Kaposiform hemangioendothelioma in children: a benign vascular tumor with multiple treatment options.
Schmid I; Klenk AK; Sparber-Sauer M; Koscielniak E; Maxwell R; Häberle B
World J Pediatr; 2018 Aug; 14(4):322-329. PubMed ID: 30054848
[TBL] [Abstract][Full Text] [Related]
4. Kaposiform hemangioendothelioma: atypical features and risks of Kasabach-Merritt phenomenon in 107 referrals.
Croteau SE; Liang MG; Kozakewich HP; Alomari AI; Fishman SJ; Mulliken JB; Trenor CC
J Pediatr; 2013 Jan; 162(1):142-7. PubMed ID: 22871490
[TBL] [Abstract][Full Text] [Related]
5. Kaposiform Hemangioendothelioma with Kasabach-Merritt Phenomenon.
Pati S; Das MK; Rana A; Das E; Sarkar S; Sherpa N; Datta S
Indian J Pediatr; 2021 Nov; 88(11):1142-1144. PubMed ID: 34106442
[TBL] [Abstract][Full Text] [Related]
6. Kaposiform hemangioendothelioma without cutaneous involvement.
Ji Y; Chen S; Li L; Yang K; Xia C; Li L; Yang G; Kong F; Lu G; Liu X
J Cancer Res Clin Oncol; 2018 Dec; 144(12):2475-2484. PubMed ID: 30293120
[TBL] [Abstract][Full Text] [Related]
7. Kaposiform hemangioendothelioma of the bone in children and adolescents.
Kuo C; Warren M; Malvar J; Miller JM; Shah R; Navid F; Luu M; Anselmo DM; Mascarenhas L
Pediatr Blood Cancer; 2022 Jan; 69(1):e29392. PubMed ID: 34606171
[TBL] [Abstract][Full Text] [Related]
8. Kaposiform lymphangiomatosis and kaposiform hemangioendothelioma: similarities and differences.
Ji Y; Chen S; Peng S; Xia C; Li L
Orphanet J Rare Dis; 2019 Jul; 14(1):165. PubMed ID: 31277673
[TBL] [Abstract][Full Text] [Related]
9. Endothelial cell malignancies in infants, children and adolescents: Treatment results of three Cooperative Weichteilsarkom Studiengruppe (CWS) trials and one registry.
Sparber-Sauer M; Koscielniak E; Vokuhl C; Schmid I; Bien E; Seitz G; Hallmen E; von Kalle T; Scheer M; Münter M; Bielack SS; Niggli F; Ljungman G; Fuchs J; Hettmer S; Rössler J; Klingebiel T;
Pediatr Blood Cancer; 2020 Mar; 67(3):e28095. PubMed ID: 31814291
[TBL] [Abstract][Full Text] [Related]
10. Sirolimus for the treatment of progressive kaposiform hemangioendothelioma: A multicenter retrospective study.
Ji Y; Chen S; Xiang B; Li K; Xu Z; Yao W; Lu G; Liu X; Xia C; Wang Q; Li Y; Wang C; Yang K; Yang G; Tang X; Xu T; Wu H
Int J Cancer; 2017 Aug; 141(4):848-855. PubMed ID: 28486787
[TBL] [Abstract][Full Text] [Related]
11. A not so harmless mass: Kaposiform hemangioendothelioma complicated by a Kasabach-Merritt phenomenon.
Tribolet S; Hoyoux C; Boon LM; Cheruy C; Demarche M; Jamblin P; Roberti A; Willemaers V; Viellevoye R; Rigo V; Broux I
Arch Pediatr; 2019 Sep; 26(6):365-369. PubMed ID: 31353149
[TBL] [Abstract][Full Text] [Related]
12. Long-term outcome for kaposiform hemangioendothelioma: A report of two cases.
Schaefer BA; Wang D; Merrow AC; Dickie BH; Adams DM
Pediatr Blood Cancer; 2017 Feb; 64(2):284-286. PubMed ID: 27701822
[TBL] [Abstract][Full Text] [Related]
13. NEWBORNS WITH KASABACH-MERRITT PHENOMENON-ASSOCIATED KAPOSIFORM HEMANGIOENDOTHELIOMA: A REPORT OF 6 CASES.
Benzar IM; Rebenkov SO; Levytskyi AF; Fedoniuk LY; Fomina LV; Sas LM; Stravskyy TY
Wiad Lek; 2020; 73(8):1785-1789. PubMed ID: 33055352
[TBL] [Abstract][Full Text] [Related]
14. Intracranial kaposiform hemangioendothelioma presenting as epistaxis: a rare case report with review of literature.
Das S; Deora H; Rao S; Kandregula S; Narayana SM
Childs Nerv Syst; 2021 Jun; 37(6):2057-2062. PubMed ID: 32989498
[TBL] [Abstract][Full Text] [Related]
15. Consensus-derived practice standards plan for complicated Kaposiform hemangioendothelioma.
Drolet BA; Trenor CC; Brandão LR; Chiu YE; Chun RH; Dasgupta R; Garzon MC; Hammill AM; Johnson CM; Tlougan B; Blei F; David M; Elluru R; Frieden IJ; Friedlander SF; Iacobas I; Jensen JN; King DM; Lee MT; Nelson S; Patel M; Pope E; Powell J; Seefeldt M; Siegel DH; Kelly M; Adams DM
J Pediatr; 2013 Jul; 163(1):285-91. PubMed ID: 23796341
[No Abstract] [Full Text] [Related]
16. Mediastinal kaposiform hemangioendothelioma and Kasabach-Merritt phenomenon in a patient with no skin changes and a normal chest CT.
Wallenstein MB; Hole MK; McCarthy C; Fijalkowski N; Jeng M; Wong WB
Pediatr Hematol Oncol; 2014 Sep; 31(6):563-7. PubMed ID: 24047193
[TBL] [Abstract][Full Text] [Related]
17. Retroperitoneal kaposiform hemangioendothelioma complicated by Kasabach-Merritt phenomenon and obstructive jaundice: A retrospective series of 3 patients treated with sirolimus.
Yao W; Li K; Wang Z; Dong K; Zheng S
Pediatr Dermatol; 2020 Jul; 37(4):677-680. PubMed ID: 32212177
[TBL] [Abstract][Full Text] [Related]
18. Kaposiform hemangioendothelioma without Kasabach-Merritt phenomenon.
Gruman A; Liang MG; Mulliken JB; Fishman SJ; Burrows PE; Kozakewich HP; Blei F; Frieden IJ
J Am Acad Dermatol; 2005 Apr; 52(4):616-22. PubMed ID: 15793511
[TBL] [Abstract][Full Text] [Related]
19. Successful Everolimus Treatment of Kaposiform Hemangioendothelioma With Kasabach-Merritt Phenomenon: Clinical Efficacy and Adverse Effects of mTOR Inhibitor Therapy.
Matsumoto H; Ozeki M; Hori T; Kanda K; Kawamoto N; Nagano A; Azuma E; Miyazaki T; Fukao T
J Pediatr Hematol Oncol; 2016 Nov; 38(8):e322-e325. PubMed ID: 26907642
[TBL] [Abstract][Full Text] [Related]
20. Kaposiform hemangioendothelioma presented with raynaud phenomenon: a case report.
Liu L; Gu W; Teng L; Xu Y; Zheng F; Hu M; Lu M; Xu X
BMC Pediatr; 2023 Nov; 23(1):574. PubMed ID: 37978357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
